Choose your location
Select your country or region to view content specific to your country.
Product News You can check out the latest product information
-
Obtained CE-IVD marking for Seeplex® FluA ACE Subtyping
Seeplex® FluA ACE Subtyping Seeplex® FluA ACE Subtyping Seegene's Seeplex® FluA ACE Subtyping has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Sep 01, 2009｜ Seeplex® FluA ACE subtyping
-
Obtained Medical Device License By Health Canada : Seeplex® RV7 Detection
Simultaneously detecting major respiratory viruses Obtained Medical Device License By Health Canada : Seeplex® RV7 Detection
Jun 24, 2009｜ Seeplex® RV7 Detection
-
Obtained CE-IVD marking for Seeplex® HPV4A ACE Screening
HPV Genotyping & Screening Seegene's Seeplex® HPV4A ACE Screening has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Jun 12, 2009｜ Seeplex® HPV4A ACE Screening
-
Obtained CE-IVD marking for Seeplex® Diarrhea ACE Detection
Detection of diarrhea-causing viruses and bacteria1Seegene's Seeplex® Diarrhea ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Jun 10, 2009｜ Seeplex® Diarrhea ACE Detection
-
Obtained CE-IVD marking for Seeplex® Meningitis ACE Detection
Seeplex® Meningitis ACE Detection Detection of viruses and bacteria causing human meningitis Seegene's Seeplex® Meningitis ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Jun 10, 2009｜ Seeplex® Meningitis ACE Detection
-
Seeplex® RV7 Detection: Obtained Medical Device License by Health Canada
Seeplex® RV7 Detection Simultaneously detecting major respiratory viruses
Jun 02, 2009｜ Seeplex® RV7 Detection
-
Launched Seeplex® UTI ACE Detection, Seeplex® MRSA ACE Detection, and Seeplex® GBS-R ACE Detection.
Seeplex® UTI ACE Detection Detection of bacteria causing urinary tract infection Launched Seeplex® UTI ACE Detection Seeplex® MRSA ACE Detection Detection of MRSA (methicillin resistant Staphylococcus aureus) Launched Seeplex® MRSA ACE Detection Seeplex® GBS-R ACE Detection Detections of GBS and erythromycin/clindamycin resistant genes Launched Seeplex® GBS-R ACE Detection.
Jun 01, 2009｜ Seeplex® UTI ACE Detection , Seeplex® MRSA ACE Detection , Seeplex® GBS-R ACE Detection
-
Launched Seeplex® STI Master ACE Detection
Seeplex® STI Master ACE Detection Total solution for the detection of pathogens causing STDs The conventional methods (ELISA, Giemsa stain, culture, etc.) to detect STI pathogens take several days or suffer from poor sensitivity. Therefore, many of the recently developed diagnostic methods employ PCR methods. Among them, Seegene's STI Master ACE Detection is outstanding in terms of sensitivity and specificity using a novel DPO technology and currently detects the largest number of pathogens causing sexually transmitted infections.
May 01, 2009｜ Seeplex® STI Master ACE Detection